Skip main navigation

Newsroom
Newsroom

Home > Newsroom > 2006 > Notice of Execution of Acquisition of the Company's Own Shares

Skip side navigation

Main contents starts here

December 26, 2006

Takeda Pharmaceutical Company Limited

Notice of Execution of Acquisition of the Company's Own Shares

Osaka, Japan, December 26, 2006 --- Takeda Pharmaceutical Company Limited ("Takeda") announced today that it completed acquisition of its own shares in the market, which was resolved by its Board of Directors on November 29, 2006.

1. Type of shares acquired: Shares of common stock
2. Period of acquisition: From November 30, 2006 to December 22,2006
3. Total number of shared acquired: 818,500 shares
4. Total value of acquisition: Yen 6,111,150,000
5. Method of acquisition: Purchased on the Tokyo Stock Exchange

(Reference)
Resolution of the Board of Directors on November 29, 2006
1. Type of shares to be acquired: Shares of common stock
2. Number of shares to be acquired: Up to 4,800 thousand shares
(equivalent to 0.54% of a total of issued shares)
3. Total value of shares to be acquired: Up to 35 billion Yen
4. Schedule of acquisition: From November 30, 2006 to December 22, 2006

# # #

Page Top